ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Ethanol → HCID 178473778、化合物

HRID 1043320
ノート
印刷プレビュー

反応式

HRID 1043320 の反応式
C(OC([N:8]1[CH2:13][C:12]([C:14]2[CH:19]=[C:18]([CH:20]3[CH2:25][CH2:24][N:23]([C:26](=[O:28])[CH3:27])[CH2:22][CH2:21]3)[CH:17]=[CH:16][C:15]=2[NH:29][C:30]([C:32]2[N:33](COCC[Si](C)(C)C)[CH:34]=[C:35]([C:37]#[N:38])[N:36]=2)=[O:31])=[CH:11][CH2:10][CH2:9]1)=O)(C)(C)C.CCO.[C:50]([OH:56])([C:52]([F:55])([F:54])[F:53])=[O:51]>C(Cl)Cl>[C:50]([OH:56])([C:52]([F:55])([F:54])[F:53])=[O:51].[F:53][C:52]([F:55])([F:54])[C:50]([OH:56])=[O:51].[C:26]([N:23]1[CH2:22][CH2:21][CH:20]([C:18]2[CH:17]=[CH:16][C:15]([NH:29][C:30]([C:32]3[NH:33][CH:34]=[C:35]([C:37]#[N:38])[N:36]=3)=[O:31])=[C:14]([C:12]3[CH2:13][NH:8][CH2:9][CH2:10][CH:11]=3)[CH:19]=2)[CH2:25][CH2:24]1)(=[O:28])[CH3:27]
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 3

HCID 702EthanolHCID 6422Trifluoroacetic acidHCID 591285915-(5-(1-Acetyl-piperidin-4-yl)-2-{[4-cyano-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazole-2-carbonyl]-amino}-phenyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester

生成物 2

HCID 6422Trifluoroacetic acid収率 0.1%HCID 178473778HCID 178473778、化合物収率 22%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

A solution of 5-(5-(1-acetyl-piperidin-4-yl)-2-{[4-cyano-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazole-2-carbonyl]-amino}-phenyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester (as prepared in the previous step, 0.40 g, 0.61 mmol) in CH2Cl2 (20 mL) and EtOH (0.4 mL) was treated with TFA (3 mL). The solution was stirred at room temperature for 0.5 h. The solvents were evaporated in vacuo, and the residue was immediately taken up in EtOH (25 mL) and stored at 5° C. for 11 h. The solution was concentrated in vacuo, and the residue was taken up in CH2Cl2 (20 mL) and EtOH (0.4 mL) then treated with TFA (6 mL). The reaction was stirred at room temperature for 2 h, and the solvents were evaporated in vacuo. Reverse phase HPLC (C-18 column) (10 to 80% acetonitrile in water with 0.1% TFA over 30 min) afforded the title compound (56.9 mg, 22%) as a white solid. 1H-NMR (CDCl3; 400 MHz): δ 8.06 (s, 1H), 7.81 (d, 1H, J=8.4 Hz), 7.32 (d, 1H, J=8.4 Hz), 7.22 (s, 1H), 6.10-6.03 (m, 1H), 4.74-4.64 (m, 2H), 4.11-4.02 (m, 1H), 3.95 (s, 2H), 3.50-3.37 (m, 2H), 3.29-3.20 (m, 1H), 2.93-2.82 (m, 1H), 2.80-2.69 (m, 1H), 2.62-2.53 (m, 2H), 2.16 (s, 3H), 1.98-1.84 (m, 2H), 1.78-1.54 (m, 2H). LC-MS (ESI, m/z): Calcd. for C23H26N6O2 419.2 (M+H). found 419.2.

後処理

  1. customThe solvents were evaporated in vacuo
  2. waitstored at 5° C. for 11 h
  3. concentrationThe solution was concentrated in vacuo
  4. additionEtOH (0.4 mL) then treated with TFA (6 mL)
  5. stirringThe reaction was stirred at room temperature for 2 h
  6. customthe solvents were evaporated in vacuo

出典と根拠

ORDレコード
ord-3a1bc0707c50487eb9556a79a2de3f4f
出典データセット
uspto-grants-2013_10
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08557847B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート